Financial results - VERAL PHARMA S.R.L.

Financial Summary - Veral Pharma S.r.l.
Unique identification code: 34708770
Registration number: J23/3159/2018
Nace: 4644
Sales - Ron
-
Net Profit - Ron
-1.562
Employee
The most important financial indicators for the company Veral Pharma S.r.l. - Unique Identification Number 34708770: sales in 2020 was - euro, registering a net profit of -1.562 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Comerţ cu ridicata al produselor din ceramică, sticlărie, şi produse de întreţinere having the NACE code 4644.
Sales - Ron18K12K335K163K02016201620172017201820182019201920202020

Sales, Profit, Employees, Debts, Capitals, Financial Results - Veral Pharma S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 18.243 12.267 335.302 162.697 0 - - -
Total Income - EUR - - 18.296 12.288 337.373 164.933 1.644 - - -
Total Expenses - EUR - - 15.395 13.304 392.106 162.872 3.242 - - -
Gross Profit/Loss - EUR - - 2.901 -1.015 -54.733 2.061 -1.597 - - -
Net Profit/Loss - EUR - - 2.352 -1.383 -57.933 616 -1.597 - - -
Employees - - 1 1 1 1 0 - - -
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate.
Sales - Ron18K12K335K163K02016201620172017201820182019201920202020
Net Profit - Ron2.4K-1.4K-58K616-1.6K2016201620172017201820182019201920202020
Employees111102016201620172017201820182019201920202020

Check the financial reports for the company - Veral Pharma S.r.l.

Rating financiar

Financial Rating -
Veral Pharma S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Veral Pharma S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Veral Pharma S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Veral Pharma S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Veral Pharma S.r.l. - CUI 34708770

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 0 0 0 489 336 - - -
Current Assets - - 23.317 8.270 49.933 27.228 27.334 - - -
Inventories - - 3.596 3.545 0 0 0 - - -
Receivables - - 2.585 2.052 44.542 27.226 26.766 - - -
Cash - - 17.136 2.674 5.391 2 568 - - -
Shareholders Funds - - 2.441 1.017 -60.399 -58.759 -59.242 - - -
Social Capital - - 89 88 86 105 103 - - -
Debts - - 21.043 7.417 87.040 86.496 86.430 - - -
Income in Advance - - 0 0 23.292 0 565 - - -
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4644 - 4644"
CAEN Financial Year 4644
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 27.334 euro in 2020 which includes Inventories of 0 euro, Receivables of 26.766 euro and cash availability of 568 euro.
The company's Equity was valued at -59.242 euro, while total Liabilities amounted to 86.430 euro. Equity decreased by -1.597 euro, from -58.759 euro in 2019, to -59.242 in 2020. The Debt Ratio was 311.4% in the year 2020.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Veral Pharma S.r.l.

Review
0.00
(0 reviews)
5 stars
(0)
4 stars
(0)
3 stars
(0)
2 stars
(0)
1 star
(0)

Comments - Veral Pharma S.r.l.

Similar services useful for checking companies and business development.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.